PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,479 stories, page 454 of 692

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07721493: Evaluation of the Safety and Effectiveness of the CORUS™ Posterior Cervical Stabilization System 3D (PCSS 3D) for the Treatment of 2-level Cervical Degenerative Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07714031: Comparative Effects of 3-Dimensional Articular and Soft Tissue Myofascial Release Approach in Patients With Overuse Syndrome of Wrist Joint

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07669129: The Effect of Full Versus Partial Coverage Thermoformed Retainers in Dual Retention With a Lower Bonded Retainer, on Periodontal, Orthodontic, and Patient-Reported Outcomes

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07606287: Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07566364: Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07502794: Long-term Assessment of Patients Treated in the ICU for Sepsis

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07474649: A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07222267: An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07025330: A Study of Efgartigimod in Patients With IgG4-Related Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07008469: Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06958107: LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06950983: Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06810622: NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06764238: Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06746831: Methamphetamine Isomer Pharmacology in Humans

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06738160: The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06719362: A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06475300: A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06266949: Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06188793: Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05970224: A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05836324: A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05407844: Community Health Worker Based Intervention to Improve Palliative Care

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05350748: Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05346809: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04749368: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02821559: Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00767312: Analysis of HIV-1 Replication During Antiretroviral Therapy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00542230: Blood Sampling for Research Related to Sickle Cell Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001645: Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

NSG Bio Accelerates Breakthrough Biotech Innovation in Singapore

Macau BusinessOriginal source
🇺🇸Industryxaira.comTier 1 · Company source

Ci Chu Bio | | Xaira Therapeutics

Xaira TherapeuticsOriginal source
🇺🇸Industryxaira.comTier 1 · Company source

Bo Wang Bio | | Xaira Therapeutics

Xaira TherapeuticsOriginal source
🇺🇸Industryxaira.comTier 1 · Company source

News & Content | Xaira Therapeutics

Xaira TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Newland Pharmaceutical Co., Ltd. Class A – SZSE:301277

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Allergy medication recalled for potential cross-contamination that could be life-threatening, FDA says

ABC News - Breaking News, Latest News and VideosOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Crystalys Therapeutics Raises $130 Million To Bring Late-Stage Gout Drug To U.S. Market

VentureburnOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Tonghua Dongbao Pharmaceutical Co., Ltd. Class A – SSE:600867

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Evercore ISI initiates Tenax Therapeutics stock coverage with outperform rating By Investing.com

Investing.com South AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech inks partnership to pair CGM+ with drug delivery system

MassDeviceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Investigating Codabakalner in a Phase 2b/3 Trial for the Treatment of Fragile X Syndrome: The CLARITY Study

NeurologyLiveOriginal source
🇪🇸Industryrovi.esTier 1 · Company source

Resultados 1S 2026

Laboratorios RoviOriginal source
🇪🇸Industryrovi.esTier 1 · Company source

Sobre resultados

Laboratorios RoviOriginal source
🇪🇸Industryrovi.esTier 1 · Company source

Nota de prensa de los resultados del primer semestre de 2026

Laboratorios RoviOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech experts want FDA drug reviews based on science, not politics

WTVBOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Discover the Top 5 Small-Cap Biotech Stocks

Investing News NetworkOriginal source
🇺🇸Researchfrazierls.comTier 2 · Direct publisher

Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

Frazier Life SciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A planned study will compare treatments in advanced kidney cancer

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Controversial Quarantine: Ebola's Legal Dilemma in the US

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aardvark shares plunge 32% after FDA halts clin...

PluangOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech experts want FDA drug reviews based on science, not politics

The Journal RecordOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Marty Makary Actually Got Done As FDA Commissioner

ForbesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Arrowhead Pharmaceuticals Inc Stock (ARWR) Closed Up by 19.04% on Jul 22: What Signal Does It Send?

TradingKeyOriginal source
🇺🇸CROinvestor.medpace.comTier 2 · Direct publisher

Medpace Holdings, Inc. Reports Second Quarter 2026 Results

MedpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA-Approved Juvéderm Filler Used in 100+ Countries

조선일보Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Oral Investigational Medicine for Pancreatic Cancer Is Accepted for FDA Review

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026?

Yahoo FinanceOriginal source
🇺🇸CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

Emergent BioSolutionsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech remains compelling even after major comeback. Here’s what investors say

CNBCOriginal source